DK166343C - Forbedret piroxicamholdigt laegemiddel - Google Patents
Forbedret piroxicamholdigt laegemiddelInfo
- Publication number
- DK166343C DK166343C DK468486A DK468486A DK166343C DK 166343 C DK166343 C DK 166343C DK 468486 A DK468486 A DK 468486A DK 468486 A DK468486 A DK 468486A DK 166343 C DK166343 C DK 166343C
- Authority
- DK
- Denmark
- Prior art keywords
- improved
- containing medicine
- piroxicam
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002702 piroxicam Drugs 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- RQFCJASXJCIDSX-UHFFFAOYSA-N 14C-Guanosin-5'-monophosphat Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(O)=O)C(O)C1O RQFCJASXJCIDSX-UHFFFAOYSA-N 0.000 abstract 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 abstract 1
- 235000013928 guanylic acid Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8501926 | 1985-10-02 | ||
| US8501926 | 1985-10-02 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK468486D0 DK468486D0 (da) | 1986-10-01 |
| DK468486A DK468486A (da) | 1987-04-03 |
| DK166343B DK166343B (da) | 1993-04-13 |
| DK166343C true DK166343C (da) | 1993-09-06 |
Family
ID=22188870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK468486A DK166343C (da) | 1985-10-02 | 1986-10-01 | Forbedret piroxicamholdigt laegemiddel |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4994457A (da) |
| EP (1) | EP0218453B1 (da) |
| JP (1) | JPS6296424A (da) |
| KR (1) | KR890001236B1 (da) |
| AT (1) | ATE49121T1 (da) |
| AU (1) | AU563822B2 (da) |
| CA (1) | CA1273875A (da) |
| DE (1) | DE3667914D1 (da) |
| DK (1) | DK166343C (da) |
| GR (1) | GR3000305T3 (da) |
| HU (1) | HU207219B (da) |
| IE (1) | IE58635B1 (da) |
| NZ (1) | NZ217778A (da) |
| PT (1) | PT83472B (da) |
| ZA (1) | ZA867494B (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5436241A (en) * | 1994-01-14 | 1995-07-25 | Bristol-Myers Squibb Company | Topical anti-inflammatory compositions containing piroxicam |
| US6797289B2 (en) * | 1998-02-13 | 2004-09-28 | Nutramax Laboratories, Inc. | Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| US20070141181A1 (en) * | 1998-02-13 | 2007-06-21 | Nutramax Laboratories, Inc. | Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| US20010000472A1 (en) * | 1998-02-27 | 2001-04-26 | Nutramax Laboratories, Inc. | L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage |
| US6555141B1 (en) | 1998-02-27 | 2003-04-29 | Nutramax Laboratories, Inc. | L-ergothioneine, Milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage |
| US20030099722A1 (en) * | 2001-10-09 | 2003-05-29 | Baxter Jeffrey H. | Methods and compositions for providing glutamine |
| ES2384294T3 (es) * | 2004-09-17 | 2012-07-03 | Ajinomoto Co., Inc. | Uso de ácido glutámico para prevenir/mejorar el trastorno digestivo funcional |
| KR101821050B1 (ko) | 2015-10-14 | 2018-03-09 | 씨제이제일제당 (주) | 바이오-기반 n-아세틸-l-메티오닌 및 이의 용도 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1029660A (en) * | 1973-06-01 | 1978-04-18 | Kyowa Hakko Kogyo Co. | Prevention of gastric lesions |
| JPS5714589A (en) * | 1980-06-27 | 1982-01-25 | Mitsui Toatsu Chem Inc | Benzothiazine derivative, its preparation and drug composition |
| GB2078738B (en) * | 1980-06-27 | 1983-11-30 | Mitsui Toatsu Chemicals | Benzothiazine derivatives |
| US4434164A (en) * | 1981-06-01 | 1984-02-28 | Pfizer Inc. | Crystalline benzothiazine dioxide salts |
| US4434163A (en) * | 1981-06-01 | 1984-02-28 | Pfizer Inc. | Water-soluble benzothiazine dioxide salts |
| US4486436A (en) * | 1982-07-22 | 1984-12-04 | Analgesic Associates | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
| US4551452A (en) * | 1983-12-21 | 1985-11-05 | Pfizer Inc. | Anti-inflammatory 2-methyl-2H-1,2-benzo-(or -thieno-)thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor |
| US4564614A (en) * | 1984-10-11 | 1986-01-14 | Pfizer Inc. | Antiinflammatory methods |
| DE3583104D1 (de) * | 1984-10-11 | 1991-07-11 | Pfizer | Piroxicam enthaltende entzuendungshemmende zusammensetzungen. |
| US4559326A (en) * | 1985-01-31 | 1985-12-17 | Pfizer Inc. | Antiinflammatory compositions and methods |
-
1986
- 1986-09-29 KR KR1019860008148A patent/KR890001236B1/ko not_active Expired
- 1986-10-01 EP EP86307505A patent/EP0218453B1/en not_active Expired - Lifetime
- 1986-10-01 AT AT86307505T patent/ATE49121T1/de not_active IP Right Cessation
- 1986-10-01 DE DE8686307505T patent/DE3667914D1/de not_active Expired - Lifetime
- 1986-10-01 ZA ZA867494A patent/ZA867494B/xx unknown
- 1986-10-01 DK DK468486A patent/DK166343C/da not_active IP Right Cessation
- 1986-10-01 CA CA000519492A patent/CA1273875A/en not_active Expired - Lifetime
- 1986-10-01 NZ NZ217778A patent/NZ217778A/xx unknown
- 1986-10-01 PT PT83472A patent/PT83472B/pt not_active IP Right Cessation
- 1986-10-01 AU AU63421/86A patent/AU563822B2/en not_active Ceased
- 1986-10-01 IE IE259986A patent/IE58635B1/en not_active IP Right Cessation
- 1986-10-02 HU HU864102A patent/HU207219B/hu not_active IP Right Cessation
- 1986-10-02 JP JP61235451A patent/JPS6296424A/ja active Granted
-
1987
- 1987-05-19 US US07/066,352 patent/US4994457A/en not_active Expired - Fee Related
-
1990
- 1990-01-17 GR GR90400017T patent/GR3000305T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ217778A (en) | 1989-03-29 |
| JPH0470285B2 (da) | 1992-11-10 |
| DK468486D0 (da) | 1986-10-01 |
| PT83472A (en) | 1986-11-01 |
| DE3667914D1 (de) | 1990-02-08 |
| HUT46216A (en) | 1988-10-28 |
| KR870003783A (ko) | 1987-05-04 |
| PT83472B (pt) | 1989-05-31 |
| JPS6296424A (ja) | 1987-05-02 |
| AU6342186A (en) | 1987-04-09 |
| DK468486A (da) | 1987-04-03 |
| EP0218453A1 (en) | 1987-04-15 |
| ZA867494B (en) | 1988-05-25 |
| US4994457A (en) | 1991-02-19 |
| IE58635B1 (en) | 1993-10-20 |
| GR3000305T3 (en) | 1991-06-07 |
| EP0218453B1 (en) | 1990-01-03 |
| CA1273875A (en) | 1990-09-11 |
| HU207219B (en) | 1993-03-29 |
| IE862599L (en) | 1987-04-02 |
| KR890001236B1 (ko) | 1989-04-28 |
| ATE49121T1 (de) | 1990-01-15 |
| DK166343B (da) | 1993-04-13 |
| AU563822B2 (en) | 1987-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA856905B (en) | Expectorant | |
| NO863671D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler. | |
| DK166343C (da) | Forbedret piroxicamholdigt laegemiddel | |
| IT8719048A0 (it) | Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica | |
| AU558587B2 (en) | Antiinflammatory composition of inositol and piroxicam | |
| PL270981A1 (en) | Pesticide containing novel derivatives of 2-phenylimidazole | |
| IT8520234A0 (it) | Composizione farmaceutiche adattivita' dopominergica. | |
| NO870834D0 (no) | Glysero-3(2)-fosfo-l-serinderivater og salter derav, fremgangsmaater for fremstilling derav og farmasoeytiske preparater inneholdende derivatene. | |
| DK310685D0 (da) | 5,6-dihydro-4h-cyklopenta(b)-tiofen-6-karboxylsyrer, fremgangsmaadetil fremstilling af dem og laegemiddelpraeparat indeholdende dem | |
| NO167801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. | |
| JPS6416755A (en) | Manufacture of n-(3',4'-dimethoxycinnamoyl)-aniline derivative | |
| AU1517788A (en) | Analogs of (1,7-DI-Alanine, des-19-leucine) | |
| IT1215261B (it) | Composizioni farmaceutiche adattivita' antigalattopoietica. | |
| AU8146887A (en) | N (halobenzoyl)n'(4-cf3-f-phenyl)- ureas & - thioureas | |
| OA08197A (fr) | Variété de clémentinier précoce "Ripetri". | |
| FI893001A0 (fi) | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 1,2-bensisoxazol-3-yl- och 1,2-bensisotiazol -3-ylderivat. | |
| IT8519281A0 (it) | 2,6-xilidide dell'acido l-n-n-propilpipecolico eprocedimento per la sua preparazione. | |
| ATE70840T1 (de) | Benzothiepino(5,4-c>pyridazin-verbindungen und ihre pharmazeutischen wirkungen. | |
| FI940103A7 (fi) | 2',3'-deoksi-2',3'-didehydronukleosidien valmistus | |
| ATE53214T1 (de) | Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate. | |
| IT208775Z2 (it) | Siringa per l'anestesia intraligamentosa. | |
| IT8422148A0 (it) | Procedimento per la preparazione dell'hopantenato di calcio. | |
| ES550484A0 (es) | Procedimiento de sintesis de 1,1'-bispirazolilmetanos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |